First human gets new antibody aimed at hepatitis C virus
Thursday, August 6, 2009 - 22:14
in Health & Medicine
Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV).